Navigation Links
Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial
Date:10/24/2011

o 18 patients. All of the first 12 patients have been transplanted in the lumbar (lower back) region of the spine. The trial will now progress to the last six patients. The first three of these will receive unilateral injections in the cervical region of the spine. The next three will receive bilateral injections in the cervical region.

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is conducting an ongoing FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, and has been awarded orphan status designation by the FDA.

In addition to ALS, the company is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, ischemic spastic paraplegia, chronic stroke, and Huntington's disease. The company has submitted an IND (Investigational New Drug) application to the FDA for a Phase I safety trial in chronic spinal cord injury.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  Neuralstem's first small molecule compound, NSI-189 is currently in a Phase I FDA-approved safety trial in major depressive disorder.  The Phase Ib portion of the trial, in depressed patients, is expected to commence later this year. Additional indications could include schizophrenia, Alzheimer's disease and bipolar disorder.

For up
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
2. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
3. Neuralstem Updates NSI-189 Major Depression Trial
4. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
5. Neuralstem Updates ALS Clinical Trial Progress
6. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
7. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
8. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
9. Neuralstems ALS Trial on Clinical Hold
10. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
11. Neuralstem Announces Issuance of Core Technology Patent in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... DENVER , Dec. 15, 2014  Colorado and ... that have legalized adult use of cannabis. Oregon ... Washington, D.C. ended prohibition during the November 2014 ... Photo - http://photos.prnewswire.com/prnh/20141212/164153LOGO The ... frequently noted and obvious benefits like the increased tax revenue ...
(Date:12/15/2014)... 2014  Stephen Squires, CEO and founder of leading ... (OTCQB:QTMM), will be speaking at the launch event ... December 16th, 2014. The RCQM launch continues Rice University,s ... top faculty and students and by inviting the world,s ... "We have a long association with Rice ...
(Date:12/15/2014)... LONDON and BOSTON , ... the leading GPCR structure-guided drug discovery and development company, ... patents in the United States ... of these patents in the US significantly strengthens the ... the major pharmaceutical markets. The suite of ...
Breaking Medicine Technology:CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2
... 2012 Due to the popular demand, ... Clinical Innovation Outsourcing Award for Dynamic Leadership in the ... Innovation Awards 2012 has been designed to highlight key ... that have improved efficiencies and furthered the definition of ...
... 28, 2012 Crothall Healthcare announced the name change ... Clinical Equipment Solutions (CES). The new name emphasizes Crothall,s ... entire cycle of healthcare technology rather than the traditional ... Crothall,s CES division will continue to focus on ...
Cached Medicine Technology:Clinical Innovation Outsourcing Awards Deadline Extension: Friday 2nd March 2Crothall Healthcare Introduces Clinical Equipment Solutions Division 2
(Date:12/17/2014)... Alan Mozes HealthDay Reporter ... holiday party season fast approaching, a new study reveals that ... arrests have fewer drunk drivers on their roads. The ... vigilantly are better able to deter inebriated revelers from getting ... new laws are being passed regarding drinking and driving," said ...
(Date:12/15/2014)... 15, 2014 Veretekk.com, Inc. announced today ... Avenue. JM Ocean Avenue has secured exclusive benefit ... automated marketing system. JM Ocean Avenue is a ... of Ocean Avenue and JM International, with partial ownership ... per year company. , “After nearly 2 decades of ...
(Date:12/15/2014)... December 15, 2014 Health Dialog, ... announced today that it has received Patient Oriented ... (NCQA) for its Disease Management (DM) Programs for ... (COPD), coronary heart disease and diabetes. This marks ... for Health Dialog’s Disease Management (DM) Programs, reaffirming ...
(Date:12/15/2014)... 15, 2014 Emergo Group, Inc., a ... countries in North and South America, Europe, the Middle ... industry participants for its 2015 Medical Device Industry Survey. ... identify upcoming business and market trends as well as ... survey targets areas including:, , Overall ...
(Date:12/15/2014)... 15, 2014 For the second year in ... “Top 30 Coffees of 2014.” Bird Rock Coffee Roasters’ Sumatra ... Zone Ethiopia at number 10. This is the first year ... Review’s selection is ranked on quality, value, and other aspects, ... 96 out of 100, and at $17.99 for 12-ounces, was ...
Breaking Medicine News(10 mins):Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... Duke University Medical Center say they may have figured ... health in women than in men. , Their study, ... found that poor sleep is associated with greater psychological ... risk of heart disease and type 2 diabetes. ...
... First Dual-Source CT System Brings More Innovative Diagnostics to the ... ... MALVERN, Pa., March 10 Encouraged by the outstanding,marketing success of ... Healthcare, (http://www.siemens.com/healthcare ) announces the 510(k) market clearance of four,new applications ...
... reality therapy for stroke patients. One commonly used program ... screen. For example, tennis balls are virtually thrown at ... hand motions are recorded on screen. In the first ... Dr. Larry Manevitz of the University of Haifa, together ...
... 10 MS Awareness Week March,10 - 17 unites ... of,multiple sclerosis nationwide in an effort to shine a ... MS, a disease where someone is,newly diagnosed each hour., ... you Do?, Ways To Join The MS Movement, ...
... -- Research published in the March issue of ... Psychological Science, is suggesting that we process images ... of the Negev Psychologist Tzvi Ganel and his ... an image common in psychological research that makes ...
... Oxfordshire, March 10 IBA,Health Group company iSOFT ... become its first healthcare channel partner in Europe ... provisioning solutions., The move coincides with the ... iSOFT to become the first partner to offer ...
Cached Medicine News:Health News:Poor sleep more dangerous for women 2Health News:Poor sleep more dangerous for women 3Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 3Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 4Health News:Virtual reality and computer technology improve stroke rehabilitation 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 3Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 4Health News:The hand can't be fooled, study shows 2Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 2Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 3Health News:iSOFT Offers Healthcare Single Sign-On Solutions After Agreement with Sentillion 4
Reliavac® 100cc low suction evacuator kits with flat drains and Y-connector tubing...
...
100cc silicone evacuator...
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag....
Medicine Products: